Guarana weight loss pills are among the most widely marketed herbal supplements in the UK, yet many consumers have little clarity on what they actually contain or whether they work. Guarana (Paullinia cupana) is a Brazilian plant whose seeds contain exceptionally high concentrations of caffeine, alongside other stimulant compounds. Frequently found in fat-burning blends and energy products, guarana is promoted for boosting metabolism, suppressing appetite, and enhancing energy. This article examines the evidence behind these claims, outlines the safety considerations and potential side effects, explains the UK regulatory position, and highlights NHS-recommended alternatives for safe, sustainable weight management.
Summary: Guarana weight loss pills contain high-caffeine plant extract that may modestly boost metabolism, but robust clinical evidence supporting meaningful or sustained weight loss is currently lacking.
- Guarana seeds contain 3–6% caffeine by dry weight — significantly higher than coffee beans — making caffeine its primary active constituent in weight loss supplements.
- EFSA has not authorised any health claims for guarana relating to weight management, reflecting insufficient and inconsistent clinical evidence.
- Common side effects include insomnia, raised heart rate, increased blood pressure, anxiety, and gastrointestinal upset; serious cardiovascular events have been reported at high doses.
- In the UK, guarana supplements are regulated as food products, not medicines, and are not required to demonstrate efficacy before being placed on the market.
- Guarana is contraindicated in pregnancy, in those with cardiovascular conditions, and in anyone taking MAOIs, anticoagulants, or other stimulant medications.
- NHS and NICE guidance recommends dietary modification, increased physical activity, behavioural support, and licensed pharmacotherapy over unregulated herbal supplements for weight management.
Table of Contents
- What Is Guarana and How Is It Used in Weight Loss Supplements?
- What Does the Evidence Say About Guarana for Weight Loss?
- Safety Considerations and Potential Side Effects
- MHRA Guidance on Weight Loss Supplements Containing Guarana
- Who Should Avoid Guarana-Based Weight Loss Pills?
- NHS-Recommended Approaches to Safe and Sustainable Weight Loss
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
What Is Guarana and How Is It Used in Weight Loss Supplements?
Guarana (Paullinia cupana) is a climbing plant native to the Amazon basin in Brazil, where its seeds have been used for centuries by indigenous communities for their stimulating properties. The seeds contain a notably high concentration of caffeine — typically around 3–6% by dry weight, compared with approximately 1–2% in coffee beans — alongside other xanthines such as theobromine and theophylline, as well as tannins and antioxidants. It is this stimulant profile that has made guarana a popular ingredient in commercially available weight loss supplements, energy drinks, and fat-burning products.
In the context of weight loss pills, guarana is most commonly included for its purported ability to:
-
Boost metabolic rate by stimulating the central nervous system
-
Suppress appetite — though this effect has not been robustly demonstrated for guarana itself in well-designed clinical trials
-
Enhance physical energy and endurance, which may support increased physical activity
-
Act as a thermogenic agent, encouraging the body to burn more calories as heat
Guarana is frequently combined with other stimulant or herbal ingredients — such as green tea extract, synephrine, or capsaicin — in proprietary blends marketed for weight management. Combining guarana with other stimulants, including synephrine or caffeine-containing ingredients, may increase cardiovascular risk beyond that of guarana alone; this is an important safety consideration. These combination products also make it difficult to isolate the specific effects of guarana itself.
In the UK, guarana-containing supplements are classified as food supplements rather than medicines, meaning they are not subject to the same rigorous pre-market efficacy and safety evaluations as licensed pharmaceutical products. Under the UK Food Information Regulations, products with added caffeine above 150 mg per litre (for drinks) must carry a high-caffeine warning; however, labelling requirements for solid-dose supplements vary, and the caffeine content per capsule or tablet is not always clearly stated. Consumers should therefore approach such products with appropriate caution and informed scepticism. Adults are generally advised to keep total caffeine intake from all sources — including coffee, tea, energy drinks, and supplements — to no more than 400 mg per day.
What Does the Evidence Say About Guarana for Weight Loss?
The scientific evidence supporting guarana as an effective standalone weight loss aid remains limited and largely inconclusive. Much of the available research focuses on caffeine — guarana's primary active constituent — rather than on guarana extract itself. Caffeine is a well-studied compound with a modest, documented effect on metabolic rate and fat oxidation. Studies and systematic reviews (including work by Hursel and Westerterp-Plantenga, 2010) suggest that caffeine can temporarily increase resting energy expenditure, though effect sizes vary considerably across doses and populations, and this effect tends to diminish with regular use as the body develops tolerance.
Some small-scale clinical studies have examined guarana specifically. A few trials have reported modest reductions in body weight and body mass index (BMI) when guarana was used as part of a multi-ingredient supplement, but these studies are generally limited by:
-
Small sample sizes and short durations
-
Lack of placebo-controlled, double-blind design
-
Confounding variables, including concurrent dietary changes and exercise
-
Industry funding, which may introduce bias
A 2001 study published in the Journal of Human Nutrition and Dietetics (Andersen et al.) found that a herbal combination including guarana produced modest weight loss over 45 days compared to placebo, but the contribution of guarana alone could not be determined, and the study was small and short-term. It is important to note that caffeine-based evidence cannot be directly extrapolated to guarana extracts, which contain additional compounds that may modify its effects.
The European Food Safety Authority (EFSA) has not authorised any health claims for guarana relating to weight management, reflecting the insufficient quality and consistency of available evidence. This position is reflected in the GB Nutrition and Health Claims register. There is currently no robust, high-quality evidence from large randomised controlled trials demonstrating that guarana independently produces clinically meaningful or sustained weight loss in humans.
Safety Considerations and Potential Side Effects
Because guarana contains high levels of caffeine, many of its side effects mirror those associated with excessive caffeine consumption. When taken in moderate amounts, guarana is generally considered safe for most healthy adults. However, the caffeine content in weight loss supplements can vary considerably and is not always clearly labelled, making it easy to inadvertently consume excessive amounts — particularly when guarana is combined with other caffeine-containing ingredients or energy drinks.
Experiencing these side effects? Our pharmacists can help you navigate them →
Adults are advised to keep total caffeine intake from all sources to no more than 400 mg per day (EFSA 2015 Scientific Opinion on the safety of caffeine). During pregnancy, the NHS advises limiting total caffeine intake to no more than 200 mg per day from all sources, as higher intakes are associated with adverse foetal outcomes including low birth weight and increased risk of miscarriage.
Common side effects associated with guarana-based weight loss pills include:
-
Insomnia and disrupted sleep patterns
-
Increased heart rate (tachycardia) and palpitations
-
Raised blood pressure
-
Anxiety, restlessness, and irritability
-
Headaches and dizziness
-
Nausea, stomach upset, and diarrhoea
-
Caffeine dependence and withdrawal symptoms upon cessation
At higher doses, more serious cardiovascular effects are possible, including arrhythmias. There have been case reports internationally linking high-dose stimulant supplements — often containing guarana — to serious adverse cardiac events, particularly in individuals with pre-existing heart conditions.
The interaction potential of guarana is also clinically relevant. Caffeine is metabolised via the CYP1A2 enzyme, and medicines that inhibit this pathway — such as ciprofloxacin — may increase caffeine levels and the risk of adverse effects. There is a theoretical concern regarding interactions with anticoagulants such as warfarin, though the clinical evidence is limited; anyone taking anticoagulants should seek pharmacist or GP advice before using guarana supplements. Guarana may also interact with monoamine oxidase inhibitors (MAOIs) and other stimulant medications. Anyone taking prescribed medicines should consult a pharmacist or GP before using guarana-containing products.
Still have questions? Message our pharmacists for free →
Long-term safety data for guarana supplementation in humans is sparse. Individuals who are pregnant or breastfeeding are advised to avoid guarana-containing products due to the high caffeine content.
If you experience severe chest pain, shortness of breath, fainting, or severe palpitations after taking a guarana-containing supplement, stop use immediately and call 999 or go to your nearest A&E department. For milder but persistent symptoms such as headache, raised heart rate, or significant anxiety, stop use and seek advice from a pharmacist or GP.
MHRA Guidance on Weight Loss Supplements Containing Guarana
In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines and medical devices are safe and effective. However, weight loss supplements containing guarana — like most herbal and food supplements — fall outside the scope of medicines regulation unless they make specific medicinal claims. They are instead regulated as food products under the remit of the Food Standards Agency (FSA) and must comply with food safety legislation, including the UK Food Information Regulations.
Under these regulations, products with added caffeine must carry appropriate labelling, including a statement that the product is not recommended for children, pregnant women, or individuals sensitive to caffeine. However, labelling requirements for solid-dose supplements are less prescriptive than for drinks, and caffeine content per dose is not always clearly disclosed. Consumers should look for products that clearly state their caffeine content per serving.
Where a herbal product makes medicinal claims, it may require either a full marketing authorisation or a Traditional Herbal Registration (THR) from the MHRA. Products sold purely as food supplements cannot legally make medicinal claims. The MHRA's borderline products guidance helps clarify when a product crosses from food supplement into medicines territory.
This regulatory distinction has important implications for consumers. Unlike licensed medicines, food supplements are not required to demonstrate efficacy before being placed on the market. Manufacturers must ensure their products are safe, but the burden of proof for effectiveness is considerably lower. The MHRA has previously issued warnings about unlicensed weight loss products — including those containing stimulant compounds — that have been found to contain undeclared or potentially harmful ingredients. Consumers should also be aware that the Advertising Standards Authority (ASA) and CAP Code regulate weight-loss and slimming claims in advertising; exaggerated or unsubstantiated claims about rapid weight loss may breach these rules.
The MHRA advises consumers to:
-
Purchase supplements only from reputable, registered retailers
-
Check the MHRA's Yellow Card scheme to report suspected adverse reactions to supplements
-
Be wary of products making exaggerated or unsubstantiated claims about rapid weight loss
-
Consult a pharmacist or GP before starting any new supplement, particularly if taking prescribed medications
The MHRA's Yellow Card reporting system is an important pharmacovigilance tool that allows both patients and healthcare professionals to report suspected adverse effects from supplements and medicines alike. If you experience an unexpected reaction to a guarana-containing product, reporting it via the Yellow Card scheme (available at yellowcard.mhra.gov.uk or via the Yellow Card app) contributes to national safety monitoring.
Who Should Avoid Guarana-Based Weight Loss Pills?
Given the stimulant nature of guarana and its high caffeine content, certain groups of people should exercise particular caution or avoid these products altogether. Healthcare professionals and pharmacists are well placed to advise individuals on whether guarana-based supplements are appropriate for their specific circumstances.
Guarana-based weight loss pills are generally not recommended for:
-
Pregnant or breastfeeding women — the NHS advises limiting total caffeine intake to no more than 200 mg per day during pregnancy; high caffeine intake is associated with increased risk of miscarriage, preterm birth, and low birth weight. High-caffeine supplements should be avoided during breastfeeding, as caffeine passes into breast milk
-
Children and adolescents — stimulant supplements are not appropriate for those under 18 years of age
-
Individuals with cardiovascular conditions — including hypertension, cardiac arrhythmias, coronary artery disease, or a history of stroke; caffeine can raise blood pressure and heart rate, potentially exacerbating these conditions and counteracting antihypertensive treatment
-
People with anxiety disorders or insomnia — caffeine can worsen symptoms significantly
-
Individuals with epilepsy — stimulant effects may be relevant to seizure threshold; medical advice should be sought
-
Those with liver or kidney disease — altered metabolism may increase the risk of toxicity
-
Individuals taking prescribed medications — particularly anticoagulants, antidepressants (especially MAOIs), antihypertensives, or other stimulants; caffeine may interact via CYP1A2 pathways or have additive stimulant effects. A pharmacist or GP should always be consulted
-
People with a history of eating disorders — appetite-suppressing supplements may reinforce disordered behaviours
It is also worth noting that individuals who are already consuming significant amounts of caffeine through coffee, tea, or energy drinks may be at greater risk of adverse effects if they additionally take guarana supplements, as total daily caffeine intake can quickly exceed the recommended maximum of 400 mg for adults. A GP or pharmacist should always be consulted before commencing any weight loss supplement, particularly in the presence of any underlying health condition or concurrent medication use.
NHS-Recommended Approaches to Safe and Sustainable Weight Loss
The NHS and NICE (National Institute for Health and Care Excellence) provide clear, evidence-based guidance on achieving and maintaining a healthy weight. These recommendations are grounded in robust clinical research and prioritise long-term health outcomes over rapid, short-term results — an important contrast to the promises often made by commercial weight loss supplements.
NICE obesity guidance recommends a multicomponent approach to weight management that includes:
-
Dietary modification — a balanced, calorie-controlled diet that creates a sustainable energy deficit, typically 500–600 kcal per day below estimated requirements
-
Increased physical activity — adults are advised to aim for at least 150 minutes of moderate-intensity aerobic activity per week, alongside strength-based exercises on two or more days, in line with the UK Chief Medical Officers' Physical Activity Guidelines
-
Behavioural support — cognitive behavioural strategies, goal-setting, and self-monitoring have strong evidence for supporting long-term weight management
-
Referral to structured weight management programmes — such as those offered through NHS Tier 2 and Tier 3 services, or the NHS Digital Weight Management Programme; Tier 4 bariatric surgery may be considered for eligible individuals in line with NICE guidance
For individuals who meet specific clinical criteria, pharmacological treatment may be considered alongside lifestyle interventions. Several medicines are currently licensed in the UK for weight management:
-
Orlistat (Xenical, prescription; alli, available over the counter) — licensed for adults with a BMI of 30 kg/m² or above, or 28 kg/m² or above in the presence of weight-related risk factors such as type 2 diabetes or hypertension
-
Semaglutide 2.4 mg (Wegovy) — a GLP-1 receptor agonist licensed for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity. NHS access in England is governed by NICE Technology Appraisal TA875, which restricts use to defined patient groups, typically within specialist weight management services
-
Liraglutide 3 mg (Saxenda) — a GLP-1 receptor agonist also licensed for weight management in adults meeting similar BMI criteria; NHS availability is subject to local commissioning decisions
-
Naltrexone/bupropion (Mysimba) — licensed for weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with weight-related comorbidities; NHS use is limited
Note that BMI thresholds for pharmacotherapy eligibility differ between individual product licences and NHS access criteria defined by NICE technology appraisals; a GP or specialist can advise on which options may be appropriate for an individual's circumstances. In some ethnic groups, lower BMI thresholds may be used to define overweight and obesity, and clinical judgement should be applied accordingly.
In summary, whilst guarana-containing weight loss pills are widely available and heavily marketed, the evidence for their efficacy is weak and their safety profile warrants careful consideration. Individuals seeking support with weight management are strongly encouraged to speak with their GP, who can provide personalised, evidence-based advice and referral to appropriate NHS services.
Frequently Asked Questions
Do guarana weight loss pills actually work for losing weight?
Guarana weight loss pills have not been shown to produce clinically meaningful or sustained weight loss in robust, large-scale clinical trials. Most available evidence relates to caffeine — guarana's main active compound — which can modestly increase metabolic rate, but this effect diminishes with regular use as tolerance develops. EFSA has not authorised any weight management health claims for guarana.
How much caffeine is in a guarana supplement, and is it safe?
Caffeine content varies considerably between products and is not always clearly labelled on guarana supplements sold in the UK. Adults are advised to consume no more than 400 mg of caffeine per day from all sources combined, including coffee, tea, energy drinks, and supplements. Exceeding this limit — which is easy to do when guarana is combined with other caffeine-containing ingredients — increases the risk of side effects such as palpitations, raised blood pressure, and anxiety.
Can I take guarana weight loss pills alongside my prescribed medication?
You should consult a pharmacist or GP before taking guarana supplements if you are on any prescribed medication. Guarana's caffeine is metabolised via the CYP1A2 enzyme, meaning drugs such as ciprofloxacin can raise caffeine levels and increase adverse effects, while interactions with anticoagulants like warfarin and monoamine oxidase inhibitors (MAOIs) are also a concern. A healthcare professional can assess whether guarana is safe alongside your specific medicines.
What is the difference between guarana supplements and licensed weight loss medicines like Wegovy or orlistat?
Licensed weight loss medicines such as semaglutide (Wegovy) and orlistat must demonstrate safety and efficacy through rigorous clinical trials before receiving MHRA marketing authorisation, and their use is governed by NICE guidance. Guarana supplements, by contrast, are regulated as food products in the UK and are not required to prove they work before being sold. This means licensed medicines offer a far higher level of evidence and regulatory oversight than guarana-based weight loss pills.
Are guarana weight loss pills safe to use during pregnancy?
Guarana weight loss pills are not safe during pregnancy and should be avoided entirely. The NHS advises pregnant women to limit total caffeine intake from all sources to no more than 200 mg per day, as higher intakes are associated with low birth weight, preterm birth, and increased risk of miscarriage. Guarana supplements can contain substantial amounts of caffeine, making it very easy to exceed this limit.
How do I report a side effect from a guarana supplement in the UK?
You can report a suspected adverse reaction to a guarana supplement via the MHRA's Yellow Card scheme, available at yellowcard.mhra.gov.uk or through the Yellow Card app. If you experience severe symptoms such as chest pain, shortness of breath, fainting, or serious palpitations, stop taking the supplement immediately and call 999 or attend your nearest A&E. For milder but persistent symptoms, stop use and seek advice from a pharmacist or GP.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
